Sites will be able to easily access systems
across multiple sponsors and studies for increased efficiency
and speed
BARCELONA, Spain, Sept. 13, 2023 /PRNewswire/ -- Veeva Systems
(NYSE: VEEV) today announced Veeva Study Portal, a free cloud
application to simplify research site access to sponsor
technologies. Study Portal will make it easy for clinical
researchers to create and share study profiles containing links to
all the relevant sponsor technology systems used for a clinical
trial. Users will be able to securely store their individual
usernames and passwords with the study profile rather than managing
multiple links, usernames, and passwords on sticky notes or
spreadsheets. Study Portal will work with all sponsor technology
systems.
In addition to Study Portal, Veeva announced VeevaID to provide
single sign-on for clinical researchers across all sponsor systems,
such as Veeva Vault EDC, Veeva Vault Study Training, and Veeva
RTSM. When sponsors use Veeva technology and enable VeevaID, the
access links in Study Portal will take the user directly to the
relevant study screen via single sign-on with no additional
username and password required.
"Research sites are focused on patient care, so alleviating the
administrative burden of managing large lists of credentials across
studies and partners is not a luxury but a necessity," said Dr.
Viviënne van de Walle, principal investigator, medical director,
PT&R. "Veeva Study Portal is a significant step forward to
simplify the technology experience for sites. By providing this at
no cost to sites, Veeva is delivering on the vision of offering
solutions that are centric to the needs of sites."
VeevaID will also be open to Veeva partners who join the VeevaID
partner program, adhere to security standards, and have integrated
the VeevaID technology. The program will allow third-party vendors
to authenticate using VeevaID for direct system entry through the
Study Portal.
Veeva Study Portal and VeevaID are planned for availability in
December 2023. Veeva provides free
technology solutions to research sites as part of its mission as a
Public Benefit Corporation (PBC). Learn more about Veeva Study
Portal at studyportal.veeva.com.
Additional Information For more on Veeva's site
solutions, visit sites.veeva.com
Connect with Veeva on LinkedIn:
linkedin.com/company/veeva-systems
About Veeva Systems
Veeva is the global leader in cloud software for the life
sciences industry. Committed to innovation, product excellence, and
customer success, Veeva serves more than 1,000 customers, ranging
from the world's largest biopharmaceutical companies to emerging
biotechs. As a Public Benefit Corporation, Veeva is committed to
balancing the interests of all stakeholders, including customers,
employees, shareholders, and the industries it serves. For more
information, visit veeva.com/eu.
Veeva Forward-looking Statements
This release contains forward-looking statements regarding
Veeva's products and services and the expected results or benefits
from use of our products and services, including certain of our new
solutions and applications that are still under development or not
generally available. These statements are based on our current
expectations. Actual results, availability, and any future events
relating to these products and services could differ materially
from those anticipated or provided in this release and we have no
obligation to update such statements. There are numerous risks that
have the potential to negatively impact our results, including the
risks and uncertainties disclosed in our filing on Form 10-Q for
the period ended July 31, 2023, which
you can find here (a summary of risks which may impact our
business can be found on pages 38 and 39), and in our subsequent
SEC filings, which you can access at sec.gov.
Contact:
|
|
Jeremy Whittaker
Veeva Systems
+49-695-095-5486
jeremy.whittaker@veeva.com
|
Deivis Mercado
Veeva Systems
925-226-8821
deivis.mercado@veeva.com
|
Logo -
https://mma.prnewswire.com/media/1488285/Veeva_Systems_Logo.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/veeva-introduces-study-portal-and-veevaid-to-streamline-research-site-trial-execution-301925368.html